Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 60,521 - 60,540 results of 112,387 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.23s Refine Results
  1. 60521
    FTIR spectra of PE, SM, and F1-F3 sphingosomes.

    FTIR spectra of PE, SM, and F1-F3 sphingosomes. by Huda Jamal AlMadalli (17952099)

    Published 2024
    “…PE-loaded sphingosomes formula (F2) was selected for having the highest EE% (71.64%), and a sustained release profile with the highest <i>in vitro</i> release (42.5±9.44%). …”
    Save to List
    Saved in:
  2. 60522
    HPLC-calibration curve of the PE in PBS (pH 7.4).

    HPLC-calibration curve of the PE in PBS (pH 7.4). by Huda Jamal AlMadalli (17952099)

    Published 2024
    “…PE-loaded sphingosomes formula (F2) was selected for having the highest EE% (71.64%), and a sustained release profile with the highest <i>in vitro</i> release (42.5±9.44%). …”
    Save to List
    Saved in:
  3. 60523
    <i>P</i>. <i>aeruginosa</i> secreted virulence factors induce ER stress in primary bronchial epithelial cells.

    <i>P</i>. <i>aeruginosa</i> secreted virulence factors induce ER stress in primary bronchial epithelial cells. by Emily F. A. van ‘t Wout (756193)

    Published 2015
    “…<p>A. Time-dependent induction of ER stress in primary bronchial epithelial cells, as assessed by <i>XBP1</i> splicing, <i>CHOP</i> and <i>GADD34</i> mRNA after treatment with CM-PAO1 (n = 5; mean ± SEM). …”
    Save to List
    Saved in:
  4. 60524
    Temporal development of coverage of <i>Termitomyces</i> diversity by GenBank ITS sequences based on optimal clustering parameters (thick lines) as well as a selection of suboptimal ones (thin lines) to assess parameter sensitivity of the overall trends.

    Temporal development of coverage of <i>Termitomyces</i> diversity by GenBank ITS sequences based on optimal clustering parameters (thick lines) as well as a selection of suboptimal... by Huxley M. Makonde (380019)

    Published 2013
    “…<p>As in Fig. 2, the clustering parameter <i>F</i> is indicated by color: light gray, <i>F</i> = 0.0; dark grey, <i>F</i> = 0.5; black, <i>F</i> = 1.0. The suboptimal threshold values were varied between 1% and 5% in steps of 1% and are either arranged in decreasing or increasing order, depending on the context; see the text for further details. …”
    Save to List
    Saved in:
  5. 60525
    DataSheet_2_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Maternal High-Fat Diet.xlsx

    DataSheet_2_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Mate... by Michael R. Bukowski (2245735)

    Published 2022
    “…Diet-dependent increases ceramide concentration at E12.5 suggest a pro-inflammatory role for HFD in early gestation. …”
    Save to List
    Saved in:
  6. 60526
    DataSheet_2_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Maternal High-Fat Diet.xlsx

    DataSheet_2_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Mate... by Michael R. Bukowski (2245735)

    Published 2022
    “…Diet-dependent increases ceramide concentration at E12.5 suggest a pro-inflammatory role for HFD in early gestation. …”
    Save to List
    Saved in:
  7. 60527
    DataSheet_1_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Maternal High-Fat Diet.docx

    DataSheet_1_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Mate... by Michael R. Bukowski (2245735)

    Published 2022
    “…Diet-dependent increases ceramide concentration at E12.5 suggest a pro-inflammatory role for HFD in early gestation. …”
    Save to List
    Saved in:
  8. 60528
    DataSheet_1_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Maternal High-Fat Diet.docx

    DataSheet_1_Lipidomic Analysis of TRPC1 Ca2+-Permeable Channel-Knock Out Mouse Demonstrates a Vital Role in Placental Tissue Sphingolipid and Triacylglycerol Homeostasis Under Mate... by Michael R. Bukowski (2245735)

    Published 2022
    “…Diet-dependent increases ceramide concentration at E12.5 suggest a pro-inflammatory role for HFD in early gestation. …”
    Save to List
    Saved in:
  9. 60529
    Table_3_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.docx

    Table_3_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  10. 60530
    Image_7_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_7_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  11. 60531
    Table_2_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.docx

    Table_2_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  12. 60532
    Image_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  13. 60533
    Image_8_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_8_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  14. 60534
    Image_4_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_4_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  15. 60535
    Image_6_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_6_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  16. 60536
    Image_2_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_2_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  17. 60537
    Image_9_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_9_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  18. 60538
    Image_3_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.TIF

    Image_3_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  19. 60539
    Table_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis.docx

    Table_1_Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With... by Yoon Ji Kim (136886)

    Published 2020
    “…In patients with T1D, insulin+sotagliflozin decreased the HbA1c level, daily insulin dose, and body weight without hypoglycemia compared with insulin monotherapy. …”
    Save to List
    Saved in:
  20. 60540
    Table_1_Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions.docx

    Table_1_Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions.docx by Guang-Yi Sun (9408809)

    Published 2022
    “…The association of risk factors with survival outcomes was evaluated using multivariable proportional hazards regression.</p>Results<p>A total of 932 patients (22.0%) received RNI. At a median follow-up of 5.9 years, the 5-year locoregional recurrence (LRR), distant metastasis (DM), disease-free survival (DFS), and overall survival (OS) rates were 4.0% and 7.2% (P = 0.001), 13.2% and 10.6% (P = 0.465), 85.0% and 84.7% (P = 0.131), and 93.9% and 92.8% (P = 0.004) in the RNI and non-RNI groups, respectively. …”
    Save to List
    Saved in:

Search Tools: